The analysis of multiple outcomes, multiple variables and variables selection in hematopoietic cell transplantation studies. Best Pract Res Clin Haematol 2023 Sep;36(3):101478
Date
08/24/2023Pubmed ID
37611996Pubmed Central ID
PMC10447944DOI
10.1016/j.beha.2023.101478Scopus ID
2-s2.0-85161269131 (requires institutional sign-in at Scopus site) 1 CitationAbstract
It is common to study time-to-event data in cancer research such as hematopoietic cell transplantation (HCT) for leukemia. The extensive work has been done for the univariate survival outcome, that is, one event type. However, in practice a subject is often exposed to multiple types of outcomes. In this article, we review various types of right-censored data with multiple outcome types including competing risks data, recurrent event data, and composite endpoints. We also provide hematopoietic cell transplantation data examples.
Author List
Kim S, Fang X, Ahn KWAuthors
Kwang Woo Ahn PhD Professor in the Institute for Health and Equity department at Medical College of WisconsinSoyoung Kim PhD Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Hematopoietic Stem Cell TransplantationHumans
Leukemia
